ASHLEY BERRY: Open Payments
NPI 1720364458 · MOREHEAD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 20 payments from 11 companies in 2025. Trend: 2023 $314 · 2024 $222 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $72 |
| Vanda Pharmaceuticals Inc. | 4 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $42 |
| Corium, LLC | 2 | $34 |
| Novo Nordisk Inc | 2 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| PFIZER INC. | 1 | $17 |
| Sage Therapeutics, LLC | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
Products named: Auvelity, CAPLYTA, HETLIOZ, Azstarys, FANAPT, FARXIGA, SPRAVATO, PREVNAR 20.
Industry payments across KY — which companies pay providers there.
